Digital Pharma
The computed 12-month bankruptcy probability of Digital Pharma is 1.0% (low). The 2024 annual accounts show negative equity (€-48k) and a net result of €-152k. Equity is shrinking by ~147.2% per year across the filed fiscal years. Its solvency ranks better than 10% of 114 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €-48k |
| Net result | €-152k |
| Staff (FTE) | 2 |
| Better than sector | 10% |
Mixed profile: strong on profitability, weaker on health.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -5.4% | 42.3% | |
| Net result | €-152k | €31k | |
| Equity | €-48k | €129k | |
| Gross operating margin | €132k | €63k | |
| Staff costs | €151k | €351k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €-19k |
| Net profit | €-152k |
| Cash flow | €-28k |
| Staff costs | €151k |
| Income taxes | €348 |
| Dividends | - |
| Total assets | €882k |
| Equity | €-48k |
| Debt | €930k |
| of which ≤ 1y | €163k |
| of which > 1y | €640k |
| Working capital | €-47k |
| Employees (FTE) | 2.0 |
| 2024 | |
|---|---|
| Current ratio | 0.71 |
| Quick ratio | 0.71 |
| Working capital ratio | -5.3% |
| Solvency | -5.4% |
| Debt / equity | -19.40 |
| Long-term debt ratio | -13.35 |
| Interest coverage | -2.15 |
| Gross margin | - |
| Net margin | - |
| ROA | -17.2% |
| ROE | 316.2% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €882k |
| Fixed assets | 21/28 | €766k |
| Intangible fixed assets | 21 | €749k |
| Tangible fixed assets | 22/27 | €16k |
| Financial fixed assets | 28 | €250 |
| Current assets | 29/58 | €117k |
| Amounts receivable within one year | 40/41 | €70k |
| Cash & bank | 54/58 | €45k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €882k |
| Equity | 10/15 | €-48k |
| Contributions / capital | 10/11 | €384k |
| Reserves | 13 | €841 |
| Accumulated profits (losses) | 14 | €-433k |
| Amounts payable | 17/49 | €930k |
| Amounts payable after one year | 17 | €640k |
| Amounts payable within one year | 42/48 | €163k |
| Trade debts payable within one year | 44 | €65k |
| Income statement | ||
| Gross operating margin | 9900 | €132k |
| Operating result | 9901 | €-142k |
| Financial income | 75 | €10 |
| Financial charges | 65 | €9k |
| Result before taxes | 9903 | €-151k |
| Income taxes | 67/77 | €348 |
| Net result for the period | 9904 | €-152k |
| Result to be appropriated | 9905 | €-152k |
| NACE primary | 63100 |
| Legal form | Private limited company(610) |
| Incorporation | 04-08-2021 |
| Status | Active |
| Postal code | 3600 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71304E0727/00T012 | Flanders | 4,715 m² | 1 · 1,974 m² | 8.4 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
13-01-2026 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2026-01-13",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0771.989.346",
"name_full": "DIGITAL PHARMA",
"legal_form": "BV"
},
"signature_regime": "solo",
"special_mandates": [
{
"quote": "\u201CAccountantsbureel Manacc\u201D, besloten vennootschap met zetel te 2440 Geel, Molenberg 4, (BE0439.641.315) evenals aan haar bedienden, aangestelden en lasthebbers wordt aangewezen als lasthebber ad hoc om, met de mogelijkheid tot indeplaatsstelling, alle formaliteiten inzake inschrijving, wijziging of stopzetting bij het Ondernemingsloket en de Kruispuntbank der Ondernemingen alsmede bij de Administratie voor de Belastingen over de Toegevoegde Waarde te vervullen en te dien einde ook alle stukken en akten te tekenen, inclusief alle benodigde documenten en formulieren jegens de bevoegde instanties en de Ondernemingsrechtbanken, en tevens alle formaliteiten te vervullen (met name ondertekening van formulieren) met betrekking tot de aansluiting of wijziging bij het sociaal verzekeringsfonds zowel voor de vennootschap als de vennootschapsmandatarissen, eventueel met verzoek om vrijstelling.",
"holder_kbo": "0439.641.315",
"holder_name": "Accountantsbureel Manacc",
"scope_categories": [
"KBO",
"tax",
"filing",
"social_security"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}29-01-2024 Capital increase of €350,000
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 350000.0,
"currency": "EUR",
"after_eur": null,
"delta_eur": 350000.0,
"before_eur": null,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-12-28",
"evidence_quote": "De vergadering besluit om het vermogen van de vennootschap \u2013 bij wijze van inbrengen in geld - te verhogen met een totaal bedrag driehonderdvijftigduizend euro (\u20AC350.000,00).",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0771.989.346",
"name_full": "DIGITAL PHARMA",
"legal_form": "BV"
}
}31-08-2021 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2021-08-24",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0771.989.346",
"name_full": "DIGITAL PHARMA",
"legal_form": "BV"
},
"signature_regime": null,
"special_mandates": [
{
"quote": "\u201CAccountantsbureel Manacc\u201D, besloten vennootschap met zetel te 2440 Geel, Molenberg 4, (BE0439.641.315) evenals aan haar bedienden, aangestelden en lasthebbers wordt aangewezen als lasthebber ad hoc om, met de mogelijkheid tot indeplaatsstelling, alle formaliteiten inzake inschrijving, wijziging of stopzetting bij het Ondernemingsloket en de Kruispuntbank der Ondernemingen alsmede bij de Administratie voor de Belastingen over de Toegevoegde Waarde te vervullen en te dien einde ook alle stukken en akten te tekenen, inclusief alle benodigde documenten en formulieren jegens de bevoegde instanties en de Ondernemingsrechtbanken, en tevens alle formaliteiten te vervullen (met name ondertekening van formulieren) met betrekking tot de aansluiting of wijziging bij het sociaal verzekeringsfonds zowel voor de vennootschap als de vennootschapsmandatarissen, eventueel met verzoek om vrijstelling.",
"holder_kbo": "BE0439.641.315",
"holder_name": "Accountantsbureel Manacc",
"scope_categories": [
"KBO",
"tax",
"filing",
"social_security"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}06-08-2021 Incorporation of a new BV
Technical details
{
"kind": "oprichting",
"seat": "3600 Genk, Slingerweg 52",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": "0870.673.483",
"name": "X-Design Pro"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": "0870.673.483",
"holder_org_name": "X-Design Pro",
"contribution_type": "in_kind",
"amount_paid_in_eur": 1648.07,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 2400,
"amount_subscribed_eur": 1648.07,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 1648.07,
"subject_company": {
"kbo": "0771.989.346",
"name_full": "Digital Pharma",
"legal_form": "BV"
},
"initial_directors": [],
"incorporation_date": "2021-07-30",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Digital Pharma |